Market Overview:
The global phenylketonuria supplement market is expected to register a CAGR of 7.5% during the forecast period, 2018-2030. The market growth can be attributed to the increasing prevalence of phenylketonuria (PKU) and rising awareness about PKU supplements among people. Based on type, the global phenylketonuria supplement market has been segmented into powder form and tablet form. The powder form segment is expected to register a higher CAGR as compared to the tablet form segment during the forecast period. This can be attributed to factors such as easy availability and lower cost of powder forms as compared to tablet forms. Based on application, the global phenylketonuria supplement market has been divided into online sales and offline sales segments.
Product Definition:
Phenylketonuria (PKU) is a rare, inherited disorder that causes the body to cannot break down phenylalanine. This amino acid builds up in the blood and can damage the brain. A phenylketonuria supplement is a special diet that helps people with this disorder manage their levels of phenylalanine.
Powder Form:
Powder form is a type of dietary supplement that contains the same amount of active ingredient as in liquid or soft gel form. It's major advantage is that it can be stored at room temperature and does not need to be refrigerated, which makes it convenient for consumers having difficulty in storing and carrying liquid supplements. Powder forms are usually used for children who do not like taking pills or prefer gels.
Tablet Form:
Tablet form is a method of delivering medication to the patient which is widely used in the market. It’s an oral dosage form that contains an amount of drug required for a specific time period. The most common way to take medicine in tablet form is by swallowing a pill with water or milk or mixing it with food if it’s not feasible to drink water along with the food.
Application Insights:
Offline sales dominated the global phenylketonuria supplement market with a share of over 60.0% in 2017. Offline channels allow consumers to directly purchase supplements from pharmacies, hospitals and clinics, health stores and other outlets which are located near their residences or workplaces. Online sales on the other hand, offer convenience for customers as they do not require physical presence at a store to purchase products however; online transactions attract higher transaction costs than offline transactions hence result in lower revenue for manufacturers.
Online sales witnessed growth due to ease of access and convenience offered along with cost-effectiveness since it reduces wastage caused by frequent visits to doctors or medical stores as well as reduces travel time required which is another factor contributing towards overall online sale share estimated at around 60% by end of forecast period 2018-19.
Regional Analysis:
North America was the largest market for the global PPK supplement, accounting for a share of more than 35.0% in 2017. The region is expected to maintain its dominance over the forecast period as well due to presence of large number of manufacturers and suppliers in this region. Moreover, increasing awareness about PKD among consumers and growing demand for nutritional products are some other factors driving growth in North America regional market.
Asia Pacific is anticipated to be one of the fastest-growing regions with a CAGR exceeding 6.5% during the forecast period owing to rising disposable income levels, improving healthcare infrastructure coupled with growing consumer awareness about available treatment options & benefits offered by these supplements leading towards improved quality of life & functioning ability thus promoting sales across this region especially in developing countries such as China & India which has been observed an increase from 1 million cases per year (2010)to 2 million cases per year (2016).
Growth Factors:
- Increasing awareness about the benefits of Phenylketonuria supplements among people.
- Rising demand for natural and organic Phenylketonuria supplements.
- Growing number of manufacturers and distributors of Phenylketonuria supplements worldwide.
- Technological advancements in the field of Phenylketonuria supplement manufacturing process that improve product quality and purity levels5
Scope Of The Report
Report Attributes
Report Details
Report Title
Phenylketonuria Supplement Market Research Report
By Type
Powder Form, Tablet Form
By Application
Online Sales, Offline Sales
By Companies
Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Schär, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary, PKU Perspectives
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
213
Number of Tables & Figures
150
Customization Available
Yes, the report can be customized as per your need.
Global Phenylketonuria Supplement Market Report Segments:
The global Phenylketonuria Supplement market is segmented on the basis of:
Types
Powder Form, Tablet Form
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Online Sales, Offline Sales
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Biomarin
- Vitaflo
- Mead Johnson
- Nutricia
- Abbott
- Dr. Schär
- Prominmetabolics
- Cambrooke
- Juvela
- Firstplay Dietary
- PKU Perspectives
Highlights of The Phenylketonuria Supplement Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Powder Form
- Tablet Form
- By Application:
- Online Sales
- Offline Sales
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Phenylketonuria Supplement Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Phenylketonuria Supplement is a dietary supplement that helps to improve the body's ability to break down phenylalanine. This can help to reduce the risk of developing phenylketonuria, a condition that affects the liver and can lead to serious health problems.
Some of the major companies in the phenylketonuria supplement market are Biomarin, Vitaflo, Mead Johnson, Nutricia, Abbott, Dr. Sch¤r, Prominmetabolics, Cambrooke, Juvela, Firstplay Dietary, PKU Perspectives.
The phenylketonuria supplement market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Phenylketonuria Supplement Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Phenylketonuria Supplement Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Phenylketonuria Supplement Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Phenylketonuria Supplement Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Phenylketonuria Supplement Market Size & Forecast, 2018-2028
4.5.1 Phenylketonuria Supplement Market Size and Y-o-Y Growth
4.5.2 Phenylketonuria Supplement Market Absolute $ Opportunity
Chapter 5 Global Phenylketonuria Supplement Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Phenylketonuria Supplement Market Size Forecast by Type
5.2.1 Powder Form
5.2.2 Tablet Form
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Phenylketonuria Supplement Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Phenylketonuria Supplement Market Size Forecast by Applications
6.2.1 Online Sales
6.2.2 Offline Sales
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Phenylketonuria Supplement Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Phenylketonuria Supplement Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Phenylketonuria Supplement Analysis and Forecast
9.1 Introduction
9.2 North America Phenylketonuria Supplement Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Phenylketonuria Supplement Market Size Forecast by Type
9.6.1 Powder Form
9.6.2 Tablet Form
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Phenylketonuria Supplement Market Size Forecast by Applications
9.10.1 Online Sales
9.10.2 Offline Sales
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Phenylketonuria Supplement Analysis and Forecast
10.1 Introduction
10.2 Europe Phenylketonuria Supplement Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Phenylketonuria Supplement Market Size Forecast by Type
10.6.1 Powder Form
10.6.2 Tablet Form
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Phenylketonuria Supplement Market Size Forecast by Applications
10.10.1 Online Sales
10.10.2 Offline Sales
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Phenylketonuria Supplement Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Phenylketonuria Supplement Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Phenylketonuria Supplement Market Size Forecast by Type
11.6.1 Powder Form
11.6.2 Tablet Form
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Phenylketonuria Supplement Market Size Forecast by Applications
11.10.1 Online Sales
11.10.2 Offline Sales
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Phenylketonuria Supplement Analysis and Forecast
12.1 Introduction
12.2 Latin America Phenylketonuria Supplement Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Phenylketonuria Supplement Market Size Forecast by Type
12.6.1 Powder Form
12.6.2 Tablet Form
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Phenylketonuria Supplement Market Size Forecast by Applications
12.10.1 Online Sales
12.10.2 Offline Sales
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Phenylketonuria Supplement Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Phenylketonuria Supplement Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Phenylketonuria Supplement Market Size Forecast by Type
13.6.1 Powder Form
13.6.2 Tablet Form
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Phenylketonuria Supplement Market Size Forecast by Applications
13.10.1 Online Sales
13.10.2 Offline Sales
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Phenylketonuria Supplement Market: Competitive Dashboard
14.2 Global Phenylketonuria Supplement Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Biomarin
14.3.2 Vitaflo
14.3.3 Mead Johnson
14.3.4 Nutricia
14.3.5 Abbott
14.3.6 Dr. Schär
14.3.7 Prominmetabolics
14.3.8 Cambrooke
14.3.9 Juvela
14.3.10 Firstplay Dietary
14.3.11 PKU Perspectives
